1. Home
  2. MAXN vs APLT Comparison

MAXN vs APLT Comparison

Compare MAXN & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maxeon Solar Technologies Ltd.

MAXN

Maxeon Solar Technologies Ltd.

HOLD

Current Price

$3.40

Market Cap

45.2M

Sector

Technology

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.11

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAXN
APLT
Founded
2019
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.2M
38.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MAXN
APLT
Price
$3.40
$0.11
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$1.25
AVG Volume (30 Days)
72.1K
27.2M
Earning Date
03-06-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$176,414,000.00
$1,000,000.00
Revenue This Year
$100.37
$124.18
Revenue Next Year
$24.61
$66.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.49
$0.11
52 Week High
$9.05
$1.50

Technical Indicators

Market Signals
Indicator
MAXN
APLT
Relative Strength Index (RSI) 54.63 25.17
Support Level $2.92 $0.21
Resistance Level $3.73 $0.26
Average True Range (ATR) 0.22 0.02
MACD 0.08 0.01
Stochastic Oscillator 57.61 7.83

Price Performance

Historical Comparison
MAXN
APLT

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, Italy, and Rest of world.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: